Sarah D. de Ferranti
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 30
-
- Blood Pressure and Hypertension Studies 15
-
- Obesity, Physical Activity, Diet 33
- Surgery top 0.5%
- Lipoproteins and Cardiovascular Health 43
- Kawasaki Disease and Coronary Complications 23
-
- Birth, Development, and Health 18
-
- Coronary Artery Anomalies 17
-
- Congenital Heart Disease Studies 14
- Co-authors
- Stephen R. DanielsNader RifaiJane W. NewburgerDariush MozaffarianSamuel S. GiddingKimberlee GauvreauDavid S. LudwigSheela N. Magge
- Cited by
- Endocrinology, Diabetes and MetabolismCardiology and Cardiovascular MedicinePublic Health, Environmental and Occupational Health
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Sarah D. de Ferranti
155 papers receiving 12.8k citations
Hit Papers
Peers
Comparison fields: 5 of 172
- Endocrinology, Diabetes and Metabolism 3.1k
- Cardiology and Cardiovascular Medicine 3.7k
- Public Health, Environmental and Occupational Health 3.1k
- Surgery 4.1k
- Pediatrics, Perinatology and Child Health 1.7k
Countries citing papers authored by Sarah D. de Ferranti
This map shows the geographic impact of Sarah D. de Ferranti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah D. de Ferranti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah D. de Ferranti more than expected).
Fields of papers citing papers by Sarah D. de Ferranti
This network shows the impact of papers produced by Sarah D. de Ferranti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah D. de Ferranti. The network helps show where Sarah D. de Ferranti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sarah D. de Ferranti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 9 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 4 | |
| 8 | 2020 | 72 | |
| 9 | 2019 | 1 | |
| 10 | Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Associationbreakdown → | 2019 | 331 |
| 11 | 2016 | 12 | |
| 12 | 2016 | 23 | |
| 13 | 2016 | 3 | |
| 14 | The Agenda for Familial Hypercholesterolemiabreakdown → | 2015 | 450 |
| 15 | 2015 | 63 | |
| 16 | 2013 | 0 | |
| 17 | 2013 | 38 | |
| 18 | 2012 | 1 | |
| 19 | 2012 | 111 | |
| 20 | La tormenta perfecta: obesidad, disfunción del adipocito y consecuencias metabólicas | 2009 | 1 |
About Sarah D. de Ferranti
Sarah D. de Ferranti is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery, having authored 168 papers that have together received 13.1k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (43 papers), Obesity, Physical Activity, Diet (33 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (30 papers), Kawasaki Disease and Coronary Complications (23 papers), Birth, Development, and Health (18 papers), Coronary Artery Anomalies (17 papers), Blood Pressure and Hypertension Studies (15 papers) and Congenital Heart Disease Studies (14 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.1k citations), Cardiology and Cardiovascular Medicine (3.7k citations) and Public Health, Environmental and Occupational Health (3.1k citations). Sarah D. de Ferranti has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Stephen R. Daniels, Nader Rifai, Jane W. Newburger, Dariush Mozaffarian, Samuel S. Gidding, Kimberlee Gauvreau, David S. Ludwig, Sheela N. Magge, Mark R. Corkins and Steven A. Abrams.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.